Creative Planning’s IDEAYA Biosciences IDYA Stock Holding History

Creative Planning’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.83M	Buy	145,028 +8,973	+7%	+$301K	﹤0.01%	1225
2025 Q4	$4.7M	Buy	136,055 +3,155	+2%	+$101K	﹤0.01%	1047
2025 Q3	$3.62M	Buy	132,900 +11,216	+9%	+$271K	﹤0.01%	1076
2025 Q2	$2.56M	Buy	121,684 +60,667	+99%	+$1.16M	﹤0.01%	1139
2025 Q1	$999K	Buy	61,017 +42,618	+232%	+$908K	﹤0.01%	1716
2024 Q4	$473K	Buy	18,399 +9,722	+112%	+$275K	﹤0.01%	2275
2024 Q3	$275K	Buy	+8,677	New	+$329K	﹤0.01%	2584
2024 Q2	–	Sell	-7,029	Closed	-$308K	–	3119
2024 Q1	$308K	Buy	7,029 +1,261	+22%	+$54.2K	﹤0.01%	2230
2023 Q4	$205K	Buy	+5,768	New	+$172K	﹤0.01%	2405

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Creative Planning's IDYA Position: Q1 2026 in Review

Creative Planning increased its IDEAYA Biosciences (IDYA) stake by 6.6% in Q1 2026, buying an estimated $301K and bringing the position to 145,028 shares worth $4.83M. The position accounts for ﹤0.01% of the portfolio, ranked #1225.

Creative Planning first reported a position in IDYA in Q4 2023 and has held it in 9 quarters since. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

Creative Planning held 145,028 shares of IDEAYA Biosciences worth $4.83M as of Q1 2026.
Creative Planning bought 8,973 IDEAYA Biosciences shares in Q1 2026, an estimated $301K.
IDEAYA Biosciences made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #1225 holding.
Creative Planning first reported a position in IDEAYA Biosciences in Q4 2023 and has held it in 9 quarters since.
253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.